CS logo
small CS logo
University of Florida Shands Cancer Center

Gainesville, Florida, United States
Hospital in Gainesville, Florida
1515 SW Archer Rd, Gainesville, FL 32608

About University of Florida Shands Cancer Center


UF Health Shands Hospital is a teaching hospital of the University of Florida in Gainesville, Florida. It is one of seven hospitals in the University of Florida Health system, and one of two campuses for UF's Health Science Center, the other being UF Health at Jacksonville.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Florida Shands Cancer Center


During the past decade, University of Florida Shands Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 50 clinical trials were completed, i.e. on average, 833.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Florida Shands Cancer Center" #1 sponsor was "Children's Oncology Group" with 35 trials, followed by "Radiation Therapy Oncology Group" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "Eastern Cooperative Oncology Group" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida Shands Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 90 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

Clinical Trials Conditions at University of Florida Shands Cancer Center


According to Clinical.Site data, the most researched conditions in "University of Florida Shands Cancer Center" are "Leukemia" (17 trials), "Lung Cancer" (12 trials), "Lymphoma" (10 trials), "Breast Cancer" (8 trials) and "Myelodysplastic Syndromes" (8 trials). Many other conditions were trialed in "University of Florida Shands Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at University of Florida Shands Cancer Center


Most popular intervention types in "University of Florida Shands Cancer Center" are "Drug" (92 trials), "Radiation" (43 trials), "Biological" (30 trials), "Procedure" (24 trials) and "Other" (14 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (25 trials), "cyclophosphamide" (17 trials), "filgrastim" (17 trials), "etoposide" (14 trials) and "cytarabine" (13 trials). Other intervention names were less common.

Clinical Trials Genders at University of Florida Shands Cancer Center


The vast majority of trials in "University of Florida Shands Cancer Center" are 95 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at University of Florida Shands Cancer Center


Currently, there are NaN active trials in "University of Florida Shands Cancer Center". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in University of Florida Shands Cancer Center, undefined suspended trials, and 11 terminated clinical trials to date.
Out of the total trials that were conducted in University of Florida Shands Cancer Center, 14 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".